These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8461032)

  • 21. Comparison of the metabolism and toxicity of dapsone in rat, mouse and man.
    Tingle MD; Mahmud R; Maggs JL; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):817-23. PubMed ID: 9353403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro.
    Coleman MD; Tingle MD; Hussain F; Storr RC; Park BK
    J Pharm Pharmacol; 1991 Nov; 43(11):779-84. PubMed ID: 1686906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The methaemoglobin forming and GSH depleting effects of dapsone and monoacetyl dapsone hydroxylamines in human diabetic and non-diabetic erythrocytes in vitro.
    Coleman MD; Holden LJ
    Environ Toxicol Pharmacol; 2004 May; 17(1):55-9. PubMed ID: 21782713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorate poisoning: mechanism of toxicity.
    Steffen C; Wetzel E
    Toxicology; 1993 Nov; 84(1-3):217-31. PubMed ID: 8266339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver.
    Ciccoli L; Ferrali M; Rossi V; Signorini C; Alessandrini C; Comporti M
    Toxicol Lett; 1999 Oct; 110(1-2):57-66. PubMed ID: 10593595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone.
    Reilly TP; Bellevue FH; Woster PM; Svensson CK
    Biochem Pharmacol; 1998 Mar; 55(6):803-10. PubMed ID: 9586952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H2O2 production, modification of the glutathione status and methemoglobin formation in red blood cells exposed to diethyldithiocarbamate in vitro.
    Sinet PM; Garber P; Jerome H
    Biochem Pharmacol; 1982 Feb; 31(4):521-5. PubMed ID: 6279106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dapsone Hydroxylamine, an Active Metabolite of Dapsone, Can Promote the Procoagulant Activity of Red Blood Cells and Thrombosis.
    Bian Y; Kim K; An GJ; Ngo T; Bae ON; Lim KM; Chung JH
    Toxicol Sci; 2019 Dec; 172(2):435-444. PubMed ID: 31428780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of in vitro methaemoglobin generation to study antioxidant status in the diabetic erythrocyte.
    Coleman MD
    Biochem Pharmacol; 2000 Nov; 60(10):1409-16. PubMed ID: 11020442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two mechanisms for toxic effects of hydroxylamines in human erythrocytes: involvement of free radicals and risk of potentiation.
    Evelo CT; Spooren AA; Bisschops RA; Baars LG; Neis JM
    Blood Cells Mol Dis; 1998 Sep; 24(3):280-95. PubMed ID: 10087986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro Protective Effect and Antioxidant Mechanism of Resveratrol Induced by Dapsone Hydroxylamine in Human Cells.
    Albuquerque RV; Malcher NS; Amado LL; Coleman MD; Dos Santos DC; Borges RS; Valente SA; Valente VC; Monteiro MC
    PLoS One; 2015; 10(8):e0134768. PubMed ID: 26284371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of K-C1 cotransport in rat red cells by a hemolytic anemia-producing metabolite of dapsone.
    Haas M; Harrison JH
    Am J Physiol; 1989 Feb; 256(2 Pt 1):C265-72. PubMed ID: 2919657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
    Winter HR; Trapnell CB; Slattery JT; Jacobson M; Greenspan DL; Hooton TM; Unadkat JD
    Clin Pharmacol Ther; 2004 Dec; 76(6):579-87. PubMed ID: 15592329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dapsone-induced hemolytic anemia: effect of N-hydroxy dapsone on the sulfhydryl status and membrane proteins of rat erythrocytes.
    Grossman SJ; Simson J; Jollow DJ
    Toxicol Appl Pharmacol; 1992 Dec; 117(2):208-17. PubMed ID: 1471153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.
    Tingle MD; Park BK
    Br J Clin Pharmacol; 1993 Jul; 36(1):31-8. PubMed ID: 8373710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theoretical mechanistic basis of oxidants of methaemoglobin formation.
    Akintonwa DA
    Med Hypotheses; 2000 Feb; 54(2):312-20. PubMed ID: 10790768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
    Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
    Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody binding.
    Bordin L; Fiore C; Zen F; Coleman MD; Ragazzi E; Clari G
    Br J Pharmacol; 2010 Nov; 161(5):1186-99. PubMed ID: 20662842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copper-induced GSH depletion and methaemoglobin formation in vitro in erythrocytes of some domestic animals and man. A comparative study.
    Sivertsen T
    Acta Pharmacol Toxicol (Copenh); 1980 Feb; 46(2):121-6. PubMed ID: 7361565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes.
    Pirmohamed M; Coleman MD; Hussain F; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1991 Sep; 32(3):303-10. PubMed ID: 1685664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.